Uete T, Matsuo K
Department of Clinical Investigation, Kitano Hospital, Tazuke Kofukai Medical Research Institute.
Jpn J Antibiot. 1990 Sep;43(9):1572-8.
A preliminary study was carried out to see whether or not the synergistic enhancement of antimicrobial activity of piperacillin (PIPC) and amikacin (AMK) in combinations against Pseudomonas aeruginosa can be evaluated using combination discs of these antibiotics. A synergistic antimicrobial effect was observed between these antibiotics, when evaluated using FIC index, against piperacillin-sensitive strains with MIC less than or equal to 12.5 micrograms/ml under the conditions of the present investigation using the agar dilution method. However, no synergy was found between these antibiotics against piperacillin-resistant strains with MIC greater than or equal to 25 micrograms/ml, even when a higher concentrations of the drugs were used. Using strains of P. aeruginosa against which the synergistic effect between these antibiotics was observed, it was found that inhibitory diameters obtained with combination discs of PIPC/AMK at concentrations of 30 micrograms/30 micrograms or 30 micrograms/15 micrograms were more than 3 mm larger than those obtained with discs containing either PIPC or AMK alone. Using strains against which no synergistic effects were observed, however, the above mentioned enlargement of inhibitory zone diameters with combination discs were not clearly found. Further studies are deemed necessary to determine whether or not the combination discs of PIPC and AMK are useful in routine clinical work.
开展了一项初步研究,以确定是否可以使用哌拉西林(PIPC)和阿米卡星(AMK)的联合药敏纸片来评估这两种抗生素联合对铜绿假单胞菌抗菌活性的协同增强作用。在本研究使用琼脂稀释法的条件下,当用FIC指数评估时,观察到这些抗生素对哌拉西林敏感菌株(MIC小于或等于12.5微克/毫升)有协同抗菌作用。然而,即使使用更高浓度的药物,这些抗生素对哌拉西林耐药菌株(MIC大于或等于25微克/毫升)之间也未发现协同作用。使用观察到这些抗生素之间有协同作用的铜绿假单胞菌菌株,发现浓度为30微克/30微克或30微克/15微克的PIPC/AMK联合药敏纸片的抑菌直径比单独含PIPC或AMK的药敏纸片的抑菌直径大3毫米以上。然而,对于未观察到协同作用的菌株,联合药敏纸片上述抑菌圈直径的增大并不明显。认为有必要进一步研究以确定PIPC和AMK的联合药敏纸片在常规临床工作中是否有用。